DT, L., M, C., MJ, O., RH, K., C, A., A, W., . . . RT, A. (2023). Treatment modification after initiating second-line medication for type 2 diabetes. The American journal of managed care, 29(12), 661. https://doi.org/10.37765/ajmc.2023.89466
Chicago Style (17th ed.) CitationDT, Liss, et al. "Treatment Modification After Initiating Second-line Medication for Type 2 Diabetes." The American Journal of Managed Care 29, no. 12 (2023): 661. https://doi.org/10.37765/ajmc.2023.89466.
MLA (9th ed.) CitationDT, Liss, et al. "Treatment Modification After Initiating Second-line Medication for Type 2 Diabetes." The American Journal of Managed Care, vol. 29, no. 12, 2023, p. 661, https://doi.org/10.37765/ajmc.2023.89466.
Warning: These citations may not always be 100% accurate.